| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate |
2002-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0038e191e2eacd483eca97757a6b21b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f292b4d9e438fa72c370750e4f0b622e |
| publicationDate |
2003-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003103972-A1 |
| titleOfInvention |
Identification and characterization of multiple splice variants of the mu-opioid receptor gene |
| abstract |
The present invention encompasses novel splice variant forms of the mu-opioid receptor-1 (MOR-1) and the polynucleotide sequences encoding the MOR-1 splice variants. The invention further encompasses methods of screening for compositions regulating the MOR-1 splice variant activities and the development of therapeutic modalities directed to regulating activity. Regulation of the MOR-1 splice variant activities may impact the physiologic processes of analgesia and weight management. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8182836-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8425933-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005070461-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8703186-B2 |
| priorityDate |
1998-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |